awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28075606-F26FDF74-AEF3-40F4-80B5-305A2D5FC95E
Q28075606-F26FDF74-AEF3-40F4-80B5-305A2D5FC95E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28075606-F26FDF74-AEF3-40F4-80B5-305A2D5FC95E
Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents
P2860
Q28075606-F26FDF74-AEF3-40F4-80B5-305A2D5FC95E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28075606-F26FDF74-AEF3-40F4-80B5-305A2D5FC95E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
186a138f7f8bd9f187f9443983e6e63bcb76d04b
P2860
A phase I/II study of the pan Bcl-2 inhibitor obatoclax mesylate plus bortezomib for relapsed or refractory mantle cell lymphoma.